Australian Market Winners: PME, SKS Stand Out as Top Picks

Three companies stand out as strong investment opportunities in the Australian market, according to analysts. Pro Medicus (PME) is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks.

The company reported revenue of $261.7 million in full year 2026, up 22.9 per cent on the prior corresponding period, and underlying net profit after tax of $144.7 million was up 24.1 per cent.

Another standout is SKS Technologies Group (SKS), which has established a significant market footprint in electrical, fibre optic and audiovisual integration for major data centre projects. Revenue of $347.93 million in full year 2026 was up 33 per cent on the prior corresponding period.